ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19

ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19

Abstract A new pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide and become pandemic with thousands new deaths and infected cases globally. To address coronavirus disease (COVID-19), currently no effective drug or vaccine is available. This necessity motivate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zeynab Fakhar, Shama Khan, Suliman Y. AlOmar, Afrah Alkhuriji, Aijaz Ahmad
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/56fdadd47ce44b4b95f39f40b4b20e7f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares